drugset / Trial / NCT02883595

Efficacy of Thymosin Alpha 1 on Improving Monocyte Function for Sepsis

NCT02883595

Phase 4 Completed 20 enrolled Sun Yat-sen University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether thymosin alpha 1 is effective on improving monocyte function and has the desired pharmacologic activity for sepsis

Timeline

Start
2016-03-31
Primary completion
2016-09-30
Completion
2016-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Thymalfasin Peptide 1.6 mg Subcutaneous